These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 28726921)

  • 1. Molecular dynamics simulations and in vitro analysis of the CRMP2 thiol switch.
    Möller D; Gellert M; Langel W; Lillig CH
    Mol Biosyst; 2017 Aug; 13(9):1744-1753. PubMed ID: 28726921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a dithiol-disulfide switch in collapsin response mediator protein 2 (CRMP2) that is toggled in a model of neuronal differentiation.
    Gellert M; Venz S; Mitlöhner J; Cott C; Hanschmann EM; Lillig CH
    J Biol Chem; 2013 Dec; 288(49):35117-25. PubMed ID: 24133216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxiredoxin interaction with the cytoskeletal-regulatory protein CRMP2: Investigation of a putative redox relay.
    Pace PE; Peskin AV; Konigstorfer A; Jasoni CJ; Winterbourn CC; Hampton MB
    Free Radic Biol Med; 2018 Dec; 129():383-393. PubMed ID: 30315937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Insights into the Altering Function of CRMP2 by Phosphorylation.
    Sumi T; Imasaki T; Aoki M; Sakai N; Nitta E; Shirouzu M; Nitta R
    Cell Struct Funct; 2018; 43(1):15-23. PubMed ID: 29479005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin mediates oxidation-dependent phosphorylation of CRMP2 and growth cone collapse.
    Morinaka A; Yamada M; Itofusa R; Funato Y; Yoshimura Y; Nakamura F; Yoshimura T; Kaibuchi K; Goshima Y; Hoshino M; Kamiguchi H; Miki H
    Sci Signal; 2011 Apr; 4(170):ra26. PubMed ID: 21521879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue.
    Martins-de-Souza D; Cassoli JS; Nascimento JM; Hensley K; Guest PC; Pinzon-Velasco AM; Turck CW
    Proteomics Clin Appl; 2015 Oct; 9(9-10):817-31. PubMed ID: 25921334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T; Yamashita N; Obara M; Araki T; Nakamura F; Kamiya Y; Alkam T; Nitta A; Nabeshima T; Mikoshiba K; Ohshima T; Goshima Y
    Neurosci Res; 2013 Nov; 77(3):180-5. PubMed ID: 23994236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the C-Terminal Tail Dynamics: Structural and Molecular Perspectives into the Therapeutic Activities of Novel CRMP-2 Inhibitors, Naringenin and Naringenin-7-O-glucuronide, in the Treatment of Alzheimer's Disease.
    Lawal MF; Olotu FA; Agoni C; Soliman ME
    Chem Biodivers; 2018 Dec; 15(12):e1800437. PubMed ID: 30290062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
    Moutal A; François-Moutal L; Perez-Miller S; Cottier K; Chew LA; Yeon SK; Dai J; Park KD; Khanna M; Khanna R
    Mol Neurobiol; 2016 Apr; 53(3):1959-1976. PubMed ID: 25846820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications.
    Hensley K; Venkova K; Christov A; Gunning W; Park J
    Mol Neurobiol; 2011 Jun; 43(3):180-91. PubMed ID: 21271304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single structurally conserved SUMOylation site in CRMP2 controls NaV1.7 function.
    Dustrude ET; Perez-Miller S; François-Moutal L; Moutal A; Khanna M; Khanna R
    Channels (Austin); 2017 Jul; 11(4):316-328. PubMed ID: 28277940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.
    Nagai J; Owada K; Kitamura Y; Goshima Y; Ohshima T
    Exp Neurol; 2016 Mar; 277():283-295. PubMed ID: 26795088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal and solution structure, stability and post-translational modifications of collapsin response mediator protein 2.
    Majava V; Löytynoja N; Chen WQ; Lubec G; Kursula P
    FEBS J; 2008 Sep; 275(18):4583-96. PubMed ID: 18699782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional protein kinase Cβ-mediated phosphorylation inhibits collapsin response-mediated protein 2 proteolysis and alleviates ischemic injury in cultured cortical neurons and ischemic stroke-induced mice.
    Yang X; Zhang X; Li Y; Han S; Howells DW; Li S; Li J
    J Neurochem; 2016 May; 137(3):446-59. PubMed ID: 26788931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the lithium-response pathway in hiPSCs implicates the phosphoregulatory set-point for a cytoskeletal modulator in bipolar pathogenesis.
    Tobe BTD; Crain AM; Winquist AM; Calabrese B; Makihara H; Zhao WN; Lalonde J; Nakamura H; Konopaske G; Sidor M; Pernia CD; Yamashita N; Wada M; Inoue Y; Nakamura F; Sheridan SD; Logan RW; Brandel M; Wu D; Hunsberger J; Dorsett L; Duerr C; Basa RCB; McCarthy MJ; Udeshi ND; Mertins P; Carr SA; Rouleau GA; Mastrangelo L; Li J; Gutierrez GJ; Brill LM; Venizelos N; Chen G; Nye JS; Manji H; Price JH; McClung CA; Akiskal HS; Alda M; Chuang DM; Coyle JT; Liu Y; Teng YD; Ohshima T; Mikoshiba K; Sidman RL; Halpain S; Haggarty SJ; Goshima Y; Snyder EY
    Proc Natl Acad Sci U S A; 2017 May; 114(22):E4462-E4471. PubMed ID: 28500272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the expression of collapsin response mediator protein-2 during synaptic plasticity in the mouse hippocampus.
    Kadoyama K; Matsuura K; Nakamura-Hirota T; Takano M; Otani M; Matsuyama S
    J Neurosci Res; 2015 Nov; 93(11):1684-92. PubMed ID: 26250894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease.
    Uchida Y; Ohshima T; Sasaki Y; Suzuki H; Yanai S; Yamashita N; Nakamura F; Takei K; Ihara Y; Mikoshiba K; Kolattukudy P; Honnorat J; Goshima Y
    Genes Cells; 2005 Feb; 10(2):165-79. PubMed ID: 15676027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of the catalytic thiolate in a mammalian glutaredoxin: structure, dynamics and electrostatics of reduced pig glutaredoxin and its mutants.
    Foloppe N; Nilsson L
    J Mol Biol; 2007 Sep; 372(3):798-816. PubMed ID: 17681533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of phosphorylated forms of WAVE1, CRMP2, and tau in Alzheimer's disease model mice: Involvement of Cdk5 phosphorylation and the effect of ATRA treatment.
    Watamura N; Toba J; Yoshii A; Nikkuni M; Ohshima T
    J Neurosci Res; 2016 Jan; 94(1):15-26. PubMed ID: 26400044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T lymphotropic virus type 1 increases T lymphocyte migration by recruiting the cytoskeleton organizer CRMP2.
    Varrin-Doyer M; Nicolle A; Marignier R; Cavagna S; Benetollo C; Wattel E; Giraudon P
    J Immunol; 2012 Feb; 188(3):1222-33. PubMed ID: 22227566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.